Analysis of gene expression profiles of Lacticaseibacillus paracasei strain Shirota from human faeces after drinking products containing LcS.

Analysis of gene expression profiles of Lacticaseibacillus paracasei strain Shirota from human faeces after drinking products containing LcS. - Analysis of gene expression profiles of Lacticaseibacillus paracasei strain Shirota from human faeces after drinking products containing LcS.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000047263

Enrollment

Registered

2022-04-16

Start date

2022-04-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Test food: Yakult 1000, Intervention period: 7 days, Amount of interventions:First 4 days 1 bottle per day, Last 3 days 3 bottles per day.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy adults

Exclusion criteria

Exclusion criteria: Subjects with habitual constipation or diarrhoea.

Design outcomes

Primary

Measure	Time frame
Gene expression profile of LcS in faeces after 4 and 7 days of treatment.	—

Countries

Japan

Contacts

Public ContactToshihiko Takada

Yakult Central Institute Gastrointestinal Function Research Laboratory Basic Research Department

toshihiko-takada@yakult.co.jp042-577-8921

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026